Cargando…

Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix

Neuroendocrine carcinoma of the cervix (NEC) is a rare and highly aggressive cervical malignancy. Given that no targeted therapy has been approved specifically to NEC, we investigated the presence of novel, potentially targetable biomarkers in a large cohort of NEC. Sixty-two NEC were molecularly pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cimic, Adela, Vranic, Semir, Arguello, David, Contreras, Elma, Gatalica, Zoran, Swensen, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132903/ https://www.ncbi.nlm.nih.gov/pubmed/33208671 http://dx.doi.org/10.1097/PAI.0000000000000884

Ejemplares similares

Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases
por: Skenderi, Faruk, et al.
Publicado: (2020)

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas
por: Topcagic, Jasmina, et al.
Publicado: (2018)

Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast
por: Vranic, Semir, et al.
Publicado: (2018)

High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
por: Gatalica, Zoran, et al.
Publicado: (2016)

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
por: Gargano, Stacey M., et al.
Publicado: (2019)

Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
por: Joneja, Upasana, et al.
Publicado: (2017)

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies
por: Willenbacher, Wolfgang, et al.
Publicado: (2018)

Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers
por: Vranic, Semir, et al.
Publicado: (2022)

TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
por: Kruslin, Bozo, et al.
Publicado: (2021)

PD-L1 testing by immunohistochemistry in immuno-oncology
por: Vranic, Semir, et al.
Publicado: (2023)

Targeting HER2 expression in cancer: New drugs and new indications
por: Vranić, Semir, et al.
Publicado: (2021)

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1
por: Gatalica, Zoran, et al.
Publicado: (2015)

An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy
por: Fojnica, Adnan, et al.
Publicado: (2023)

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients
por: Nikanjam, Mina, et al.
Publicado: (2019)

Comparison of the biomarkers for targeted therapies in primary extra‐mammary and mammary Paget's disease
por: Gatalica, Zoran, et al.
Publicado: (2020)

Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
por: Vranic, Semir, et al.
Publicado: (2020)

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases
por: Gatalica, Zoran, et al.
Publicado: (2014)

Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast
por: Gatalica, Zoran, et al.
Publicado: (2015)

NUTM1-Rearranged Neoplasms—A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations—An Updated Review
por: Luo, Wenyi, et al.
Publicado: (2021)

PD-L1 Status in Refractory Lymphomas
por: Vranic, Semir, et al.
Publicado: (2016)

Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group
por: Vranic, Semir, et al.
Publicado: (2022)

Assay‐agnostic spatial profiling detects tumor microenvironment signatures: new diagnostic insights for triple‐negative breast cancer
por: Ziegler, Colleen, et al.
Publicado: (2023)

Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
por: Tomic, Kresimir, et al.
Publicado: (2023)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

Acinic cell carcinoma of the breast: A comprehensive review
por: Ajkunic, Azra, et al.
Publicado: (2022)

HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
por: Skenderi, Faruk, et al.
Publicado: (2022)

Large-cell neuroendocrine carcinoma of the cervix
por: Yoseph, Benyam, et al.
Publicado: (2012)

Neuroendocrine carcinoma of cervix and review literature
por: Verma, Saransh, et al.
Publicado: (2023)

Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literature
por: Vranic, Semir, et al.
Publicado: (2008)

Recurrent Neuroendocrine Tumor of the Cervix Presenting With Ectopic Cushing’s Syndrome
por: Rico, Jeffrey G, et al.
Publicado: (2022)

Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix
por: Zhu, Ran, et al.
Publicado: (2019)

Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances
por: Chao, Angel, et al.
Publicado: (2023)

Oncocytoma-Like Renal Tumor With Transformation Toward High-Grade Oncocytic Carcinoma: A Unique Case With Morphologic, Immunohistochemical, and Genomic Characterization
por: Sirintrapun, Sahussapont J., et al.
Publicado: (2014)

Neuroendocrine Carcinoma of Cervix: A Case Series
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients
por: Heestand, Gregory M., et al.
Publicado: (2017)

Neuroendocrine carcinoma of the cervix: a systematic review of the literature
por: Tempfer, Clemens B., et al.
Publicado: (2018)

Comparative genomics of high grade neuroendocrine carcinoma of the cervix
por: Hillman, R. Tyler, et al.
Publicado: (2020)

Molecular profiling of head and neck squamous cell carcinoma
por: Feldman, Rebecca, et al.
Publicado: (2015)

A Nomogram Model Based on Neuroendocrine Markers for Predicting the Prognosis of Neuroendocrine Carcinoma of Cervix
por: Jia, Mingzhu, et al.
Publicado: (2023)

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
por: Smaglo, Brandon G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u4t8kgju0ijjsgd9ite83qs4lv